Kara Keedy

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 100 citations

Antimicrobial Stewardship, Antibiotics, Community-acquired Bacterial Pneumonia +8

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia

Thomas M. File, Barbara Rewerska, Violeta Vučinić-Mihailović et al. · Clinical Infectious Diseases · 2016 · 71 citations · Full text

A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug–Drug Interaction

Richard Pushkin, Maria D. Iglesias-Ussel, Kara Keedy et al. · Clinical Infectious Diseases · 2016 · 43 citations · Full text

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial

Sandra P. McCurdy, Kara Keedy, Laura Lawrence et al. · Antimicrobial Agents and Chemotherapy · 2019 · 34 citations · Full text

Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents

Daniel González, Debra L. Palazzi, Leena Bhattacharya-Mithal et al. · Antimicrobial Agents and Chemotherapy · 2016 · 15 citations · Full text

Antimicrobial Stewardship, Dried Blood Spots, Drug Monitoring +19